Reduced oxygenation in human obese adipose tissue is associated with impaired insulin suppression of lipolysis

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 4052-4055

  Pasarica, Magdalena ^a   Rood, Jennifer ^a   Ravussin, Eric ^a   Schwarz, Jean Marc ^a   Smith, Steven R ^a   Redman, Leanne M ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL; INSULIN; MESSENGER RNA; OSMIUM; VASCULOTROPIN;

ADIPOSE TISSUE; ARTICLE; BIOPSY; CAPILLARY DENSITY; CELL SIZE; CLINICAL ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ELECTRODE; FEMALE; GENE EXPRESSION; GLUCOSE CLAMP TECHNIQUE; HISTOLOGY; HUMAN; HYPOXIA; INSULIN SENSITIVITY; LIPOLYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; OXYGENATION; PRESSURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNIVERSITY;

EID: 77955404793     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2377     Document Type: Article

References (16)

1. DeFronzo RA, Bonadonna RC, Ferrannini E 1992 Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318-368
2. Trayhurn P, Wood IS 2004 Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347-355 (Pubitemid 40277057)
3. Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, Rood JC, Burk DH, Smith SR 2009 Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 58:718-725
4. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, Shimomura I 2007 Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56:901-911 (Pubitemid 46525054)
5. Wang B, Wood IS, Trayhurn P 2007 Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 455:479-492 (Pubitemid 47624196)
6. Ye J, Gao Z, Yin J, He Q 2007 Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293:E1118-E1128
7. Bays H, Mandarino L, DeFronzo RA 2004 Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89:463-478
8. Smith SR, Ravussin R 2006 Role of adipocyte in metabolism and endocrine function. In: DeGroot LJ, Jameson JL, eds. Endocrinology. 5th ed. Philadelphia: Elsevier Saunders; 1045-1062
9. Hirsch J, Gallian E 1968 Methods for the determination of adipose cell size in man and animals. J Lipid Res 9:110-119
10. Wolfe RR, Chinkes DL 2005 Isotope tracers in metabolic research: principles and practice of kinetic analysis. Hoboken, NJ: John Wiley, Sons
11. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830
12. Koutsari C, Jensen MD 2006 Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res 47:1643-1650
13. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE 2004 Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279:12152-12162
14. De Costre P, Buhler U, DeGroot LJ, Refetoff S 1971 Diurnal rhythm in total serum thyroxine levels. Metabolism 20:782-791
15. Smith SR, Wilson PW 2006 Free fatty acids and atherosclerosis: guilty or innocent? J Clin Endocrinol Metab 91:2506-2508
16. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiéra F, Sharma AM 2003 The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 35:807-825